The U.S. Food and Drug Administration (FDA) will host a public meeting in November to discuss ongoing efforts to evaluate dental amalgam and metal-containing implants and to address potential safety questions.
Read more on DrBicuspid.com
The U.S. Food and Drug Administration (FDA) will host a public meeting in November to discuss ongoing efforts to evaluate dental amalgam and metal-containing implants and to address potential safety questions.
No comments:
Post a Comment